Codexis (CDXS) Asset Writedowns and Impairment (2013 - 2025)
Codexis' (CDXS) quarterly Asset Writedowns and Impairment came in at -$113000.0 in Q1 2025, down 104.04% quarter-over-quarter from $2.8 million in Q4 2024.
Codexis (CDXS) Asset Writedowns and Impairment (2013 - 2025) Analysis & Trends
Codexis' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at -$113000.0 for Q1 2025.
- On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to -$113000.0 in Q1 2025; TTM through Dec 2025 was -$113000.0, a 101.65% decrease from a year earlier, with the FY2025 full-year figure at -$113000.0, down 101.64% from the prior year.
- Asset Writedowns and Impairment retreated to -$113000.0 in Q1 2025 per CDXS's latest filing, from $2.8 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $7.7 million in Q3 2023 and bottomed at -$113000.0 in Q1 2025.
- The 4-year median for Asset Writedowns and Impairment is $1.2 million (2023), against an average of $2.3 million.
- Across the five-year window, Asset Writedowns and Impairment jumped 285.85% in 2023 and tumbled 49.35% in 2024, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $311000.0 in 2022, then soared by 285.85% to $1.2 million in 2023, then jumped by 133.33% to $2.8 million in 2024, then sank by 104.04% to -$113000.0 in 2025.
- Per Business Quant, the three latest CDXS Asset Writedowns and Impairment figures stand at -$113000.0 (Q1 2025), $2.8 million (Q4 2024), and $3.9 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - |
| 10 | Codexis | 138.88 Mn | 73.74 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -113,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Dec 31, 2023 | 1.20 Mn |
| Dec 31, 2023 | 1.20 Mn |
| Sep 30, 2023 | 7.70 Mn |
| Sep 30, 2023 | 7.70 Mn |
| Dec 31, 2022 | 311,000.00 |
| Dec 31, 2022 | 311,000.00 |
| Dec 31, 2014 | 1.79 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 1.84 Mn |
| Sep 30, 2014 | 1.84 Mn |
| Jun 30, 2014 | 1.80 Mn |
| Jun 30, 2014 | 1.80 Mn |